HHS buys another 375,000 doses of flu vaccine

Influenza, General

Dec 15, 2003 (CIDRAP News) – The Department of Health and Human Services (HHS) is buying 375,000 doses of influenza vaccine from British drug maker Chiron to boost the nation's waning vaccine supply, HHS Secretary Tommy Thompson announced today.

In addition, HHS has negotiated a contract for 3 million doses of the intranasal vaccine FluMist that state and local health departments can buy if needed, Thompson announced.

Thompson said the Chiron vaccine is a type already licensed and in use in the United States. Currently in bulk form, the vaccine needs to be packaged and will become available in January. "The vaccine will be made available for state and local purchase according to an allocation system designed to ensure equitable distribution of vaccine," the HHS announcement said.

Chiron is one of only two current manufacturers of injectable flu vaccine for the US market. Thompson announced Dec 11 that HHS was buying 250,000 doses of flu vaccine from the other major manufacturer, Aventis Pasteur. That purchase included 100,000 doses of adult vaccine, available immediately, and 150,000 doses of children's vaccine to become available in January.

About 83 million doses of flu vaccine were produced for the United States this year, including about 4 million doses of FluMist, federal officials have said. The intranasal vaccine is currently approved only for healthy people between the ages of 5 and 49 years.

Today's announcement did not list the cost of the Chiron vaccine or explain how the FluMist contract will work, and details were not immediately available from HHS.

Because of growing shortages of injectable vaccine, the Centers for Disease Control and Prevention (CDC) recommended last week that people at high risk for flu complications be first in line for the shots. Those groups include healthy children aged 6 to 23 months, people 65 years or older, pregnant women in their second or third trimester during the flu season, and anyone 2 years or older who has a chronic health condition.

Healthcare workers and others in contact with people in high-risk groups should be next in line for injectable vaccine, the CDC advised. The agency also said that healthy people aged 5 to 49 should be encouraged to get FluMist, which is made by MedImmune and distributed by Wyeth.

See also:

HHS news release
http://archive.hhs.gov/news/press/2003pres/20031215.html

This week's top reads

  1. Wastewater testing finds H5N1 avian flu in 9 Texas cities

    Wastewater detections began in early March, and so far sequencing hasn't found any mutations linked to human adaptation.

    Lisa Schnirring
    wastewater treatment plant

  2. CDC launches new influenza A wastewater dashboard; states report more H5N1 in dairy herds

    The tracker will help with surveillance, but it doesn't distinguish the influenza A subtype or determine the source of the virus.

    Lisa Schnirring
    wastewater collection

  3. USDA experiments suggest H5N1 not viable in properly cooked ground beef

    Federal officials said it's unclear if dairy cow outbreaks are peaking, and they haven't made much headway testing farm workers for avian flu virus.

    Lisa Schnirring
    cooking burgers

  4. Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients

    A total of 76% of patients were prescribed antibiotics.

    Mary Van Beusekom

  5. Feds announces assistance for US farmers affected by H5N1 avian flu

    The assistance is meant to both improve on-site biosecurity and address financial losses connected to lost milk production in herds affected by H5N1.

    Stephanie Soucheray
    cows

  6. USDA confirms 3 more H5N1 outbreaks in dairy herds

    Of the three newly confirmed outbreaks, two are in Michigan and one is in Idaho.

    Lisa Schnirring

  7. Study: Before vaccines, 44% of COVID-19 patients in ICU died

    The overall case-hospitalization rate among patients was 5.7%.

    Stephanie Soucheray
    tired doc

  8. Drug-resistant Trichophyton fungus represents emerging threat in US

    Retrospective reviews suggest the earliest confirmed US isolate was from 2017. 

    Stephanie Soucheray
    tinea

  9. Data: Heart-failure patients have 82% better odds of living longer if vaccinated against COVID

    Vaccinated patients also had a 47% lower risk of hospitalization for heart failure and a 13% reduced risk of infection over 6 months.

    Mary Van Beusekom
    COVID vaccination in woman wearing pearls

  10. Hospital COVID patients 35% more likely to die than flu patients last winter, study suggests

    The results should be interpreted in the context of twice as many hospitalizations for COVID than flu during the study period, the authors say.

    Mary Van Beusekom
    Hospital patient